# Rare eye condition prompts new FDA warning on popular GLP-1 drugs

Source: [Medical Xpress - latest medical and health news stories](https://medicalxpress.com/news/2026-11-rare-eye-condition-prompts-fda.html) · 2026-11-10 · Medicine
Page: https://themorning.science/story/rare-eye-condition-prompts-new-fda-warning-on-popular-glp-1-drugs-b736061112389727
Kind: policy · Impact: medium

## In brief

- The FDA is requiring makers of GLP-1 drugs such as Ozempic and Wegovy to add a warning about a rare eye condition.
- The condition can cause vision loss.
- The requirement was reported by Medical Xpress on 2026-11-10.

## Why it matters

Clinicians and patients using GLP-1 drugs will see a new labeled warning about a rare cause of vision loss, which may affect how these drugs are prescribed and monitored.

## Timeline

- 2026-11-10: Medical Xpress reports that the FDA is requiring GLP-1 drug makers to warn of a rare eye condition

## Coverage

- [Rare eye condition prompts new FDA warning on popular GLP-1 drugs](https://medicalxpress.com/news/2026-11-rare-eye-condition-prompts-fda.html) — Medical Xpress - latest medical and health news stories, 2026-11-10

Tags: glp-1, fda, drug safety, eye health, regulation

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science